Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
Status:
Not yet recruiting
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, open, single-dose, 3 period partial replicated crossover-design
study to investigate the pharmacokinetic profiles and safety of CKD-333 in healthy
volunteers.